Fujimura Masato, Ishimaru Hironobu
Fujimura Animal Allergy Hospital, Aomatanihigashi 5-10-26, Minou-shi, Osaka 562-0022, Japan.
J Vet Med. 2014;2014:492735. doi: 10.1155/2014/492735. Epub 2014 Sep 21.
This study investigated the influence of 0.00584% hydrocortisone aceponate spray (HCA; Cortavance Virbac SA, Carros, France) on blood serum cortisol levels and peripheral blood CCR4(+) CD4(+) T-lymphocyte levels in dogs with atopic dermatitis. Patients were randomly divided into group I (N = 8) and group II (N = 8). The dogs in group I were sprayed with HCA on the affected skin once a day for three weeks. The dogs in group II were treated once a day for 3 days followed by no treatment for 4 days for a total of three weeks. For the dogs in group I and group II the CADESI-03 scores before and after use of HCA showed significant reduction (P < 0.01). The postcortisol level after the use of HCA in group I showed 36.0% decrease and showed significant suppression (P < 0.01). By comparison, the use of HCA on group II did not show decrease in postcortisol levels. There was a tendency of suppression for hypothalamus-pituitary gland-adrenal gland system, but it was not serious influence. In addition, there was no influence on peripheral blood CCR4(+) CD4(+) lymphocytes percentage in dogs in group I after treatment with HCA.
本研究调查了0.00584%的醋酸氢化可的松喷雾剂(HCA;法国卡罗斯威巴克动物保健公司的Cortavance)对特应性皮炎犬血清皮质醇水平和外周血CCR4(+) CD4(+) T淋巴细胞水平的影响。将患犬随机分为I组(N = 8)和II组(N = 8)。I组患犬在患部皮肤每天喷洒一次HCA,持续三周。II组患犬每天治疗一次,连续治疗3天,然后4天不治疗,共持续三周。对于I组和II组患犬,使用HCA前后的CADESI - 03评分均显著降低(P < 0.01)。I组使用HCA后的皮质醇水平降低了36.0%,且表现出显著抑制(P < 0.01)。相比之下,II组使用HCA后皮质醇水平未降低。下丘脑 - 垂体 - 肾上腺系统有抑制趋势,但影响不严重。此外,I组患犬经HCA治疗后,外周血CCR4(+) CD4(+)淋巴细胞百分比无影响。